The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.


Pulmonary hypertension in idiopathic pulmonary fibrosis: a review.

TitlePulmonary hypertension in idiopathic pulmonary fibrosis: a review.
Publication TypeJournal Article
Year of Publication2011
AuthorsPitsiou, G., Papakosta D., & Bouros D.
Date Published2011
KeywordsAntihypertensive Agents, Cardiac Catheterization, Echocardiography, Doppler, Female, Humans, Hypertension, Pulmonary, Idiopathic Pulmonary Fibrosis, Male, Predictive Value of Tests, Prognosis, Respiratory Function Tests, Risk Factors

Idiopathic pulmonary fibrosis (IPF) is a progressive diffuse parenchymal disease with a poor prognosis. Pulmonary hypertension (PH) often complicates the course of IPF and may even be found in patients with preserved lung function. Possible pathogenetic mechanisms of PH in IPF include vascular destruction, pulmonary hypoxic vasoconstriction and vascular remodeling due to overexpression of cytokines and growth factors. PH in IPF patients is associated with decreased exercise capacity and a worse prognosis. Due to its prognostic significance, it seems important to investigate for PH in these patients. As the symptoms of PH in IPF are nonspecific, the development of PH in a patient with known IPF can be easily overlooked. Noninvasive methods provide clues for the diagnosis, but their sensitivity is limited. Doppler echocardiography is a useful tool for the detection of PH which also provides additional information regarding associated cardiac abnormalities. However, right heart catheterization remains the gold standard diagnostic test. Therapeutic options for PH in IPF are limited. Long-term oxygen administration for the correction of hypoxemia should be recommended. The availability of new pharmacological agents in the treatment of PH has raised the possibility of therapy in patients with IPF and associated PH. Whether these PH-targeted therapies may be of benefit in this patient group, in terms of improving functional outcomes and survival, remains uncertain.

Alternate JournalRespiration
PubMed ID21677422


Secretariat of the School of Medicine


School of Medicine's presence in social networks
Follow Us or Connect with us.